MDM2 and sarcoma: Furthermore, a suspected locoregional recurrence of a dedifferentiated liposarcoma was reclassified as a secondary, radiotherapy-associated sarcoma based on the absence of MDM2/CDK4 co-amplification and widespread deletions with flanking microhomology, a signature that has been associated with ionizing radiation [26].